美国 · SEC FORM 4
Arcutis Biotherapeutics, Inc.
ARQT · Nasdaq · CIK 0001787306 · Healthcare · Biotechnology
内部人信号
0 qualifying P purchase groups
当前 180 天评分窗口
51 同一窗口内观察到的 Form 4 交易行
25 sales · 26 期权、代扣税、授予、赠与或其他交易行
为什么没有活跃信号？
评分构成
活跃窗口内没有合资格买入，因此不计算分数。缺失的输入不会被当作零分或看空信号。
为什么没有分数？
- 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
- 卖出及其他 Form 4 活动继续作为背景显示，不会形成负分。
卖出和其他 Form 4 活动会单独显示，不会形成负面买入信号。没有买入不会被评分为看空。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。
Showing the six most active owners; 7 additional owner(s) remain in Form 4 申报证据.
买方广度、集中度与聚集买入
合资格买入进入 180 天研究窗口后，这些模块才会启用。
信号历史
Scores are archived only when the company qualifies for a published US buy-signal snapshot. 最近一次合资格买入: 2025-06-13 · Heron Patrick J.
近期 Form 4 活动
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
市场背景补充近期价格表现与风险信息，不影响内部人信号。
价格表现
- 1M
- -0.9%
- 3M
- -16.0%
- 6M
- -1.8%
- 12M
- +22.3%
波动率与流动性
- 波动率
- 60.9%
- Beta
- —
- 平均每日成交额
- USD 53.7M
估值
- 市值
- —
- P/E
- —
基本面
- 利润率
- -4.3%
- ROE
- -8.5%
- 细分行业
- Biotechnology
市场数据
价格数据截至：2026-10-07 · 价格来源：OpenBB/yfinance; 成交量来自 本机价格缓存 (yfinance) · 来自 SEC 申报文件：利润率, ROE · 财年截止日：2025-12-31 · Status: PASS
空头余额
空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。
- 空头股数
- 21,688,918
- 上期报告
- 18,458,091
- 日均成交量
- 4,493,016
- 回补天数
- 4.8
FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2025-06-13 | Heron Patrick J | 买入 (P) | Common Stock | 2,646 | USD 13.08 | USD 34,610 | SEC 申报 ↗ |
| 2025-06-05 | Heron Patrick J | 买入 (P) | Common Stock | 378 | USD 13.41 | USD 5,069 | SEC 申报 ↗ |
| 2025-06-04 | Heron Patrick J | 买入 (P) | Common Stock | 1,890 | USD 13.32 | USD 25,175 | SEC 申报 ↗ |
| 2025-05-22 | Heron Patrick J | 买入 (P) | Common Stock | 2,520 | USD 13.65 | USD 34,398 | SEC 申报 ↗ |
| 2025-05-21 | Heron Patrick J | 买入 (P) | Common Stock | 2,520 | USD 13.66 | USD 34,423 | SEC 申报 ↗ |
| 2025-05-15 | Heron Patrick J | 买入 (P) | Common Stock | 2,520 | USD 13.62 | USD 34,322 | SEC 申报 ↗ |
| 2025-05-14 | Heron Patrick J | 买入 (P) | Common Stock | 6,300 | USD 13.76 | USD 86,688 | SEC 申报 ↗ |
| 2025-05-13 | Heron Patrick J | 买入 (P) | Common Stock | 2,374 | USD 13.76 | USD 32,666 | SEC 申报 ↗ |
| 2025-05-09 | Heron Patrick J | 买入 (P) | Common Stock | 6,300 | USD 13.60 | USD 85,680 | SEC 申报 ↗ |
| 2024-11-30 | Watanabe Todd Franklin | 买入 (P) | Common Stock | 2,038 | USD 7.11 | USD 14,490 | SEC 申报 ↗ |
| 2024-11-30 | Matsuda Masaru | 买入 (P) | Common Stock | 1,657 | USD 7.11 | USD 11,781 | SEC 申报 ↗ |
| 2024-11-30 | Edwards Larry Todd | 买入 (P) | Common Stock | 1,093 | USD 7.11 | USD 7,771 | SEC 申报 ↗ |
| 2024-05-31 | Watanabe Todd Franklin | 买入 (P) | Common Stock | 4,000 | USD 1.69 | USD 6,760 | SEC 申报 ↗ |
| 2024-05-31 | Matsuda Masaru | 买入 (P) | Common Stock | 4,000 | USD 1.69 | USD 6,760 | SEC 申报 ↗ |
| 2024-03-04 | Heron Patrick J | 买入 (P) | Common Stock | 21,052 | USD 9.50 | USD 199,994 | SEC 申报 ↗ |
Form 4 申报证据
119 transaction lines in the latest 365-day window; 675 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-09-16 | Matsuda Masaru | 卖出 (S) | Common Stock | 3,674 | USD 25.00 | USD 91,850 | SEC 申报 ↗ |
| 2026-09-15 | Welgus Howard G. | 卖出 (S) | Common Stock | 4,730 | USD 24.18 | USD 114,371 | SEC 申报 ↗ |
| 2026-09-15 | Welgus Howard G. | 期权行权／转换 (M) | Common Stock | 4,096 | USD 7.93 | USD 32,473 | SEC 申报 ↗ |
展开近期 Form 4 证据 (30 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-09-16 | Matsuda Masaru | 卖出 (S) | Common Stock | 3,674 | USD 25.00 | USD 91,850 | SEC 申报 ↗ |
| 2026-09-15 | Welgus Howard G. | 卖出 (S) | Common Stock | 4,730 | USD 24.18 | USD 114,371 | SEC 申报 ↗ |
| 2026-09-15 | Welgus Howard G. | 期权行权／转换 (M) | Common Stock | 4,096 | USD 7.93 | USD 32,473 | SEC 申报 ↗ |
| 2026-09-08 | Matsuda Masaru | 卖出 (S) | Common Stock | 9,989 | USD 25.03 | USD 250,025 | SEC 申报 ↗ |
| 2026-08-27 | Curran Terrie | 卖出 (S) | Common Stock | 38,200 | USD 25.03 | USD 956,146 | SEC 申报 ↗ |
| 2026-08-27 | Curran Terrie | 期权行权／转换 (M) | Common Stock | 38,200 | USD 8.30 | USD 317,180 | SEC 申报 ↗ |
| 2026-08-20 | Curran Terrie | 卖出 (S) | Common Stock | 1,072 | USD 26.04 | USD 27,915 | SEC 申报 ↗ |
| 2026-08-20 | Curran Terrie | 期权行权／转换 (M) | Common Stock | 1,072 | USD 7.51 | USD 8,051 | SEC 申报 ↗ |
| 2026-08-19 | Burnett Patrick | 卖出 (S) | Common Stock | 1,697 | USD 27.00 | USD 45,819 | SEC 申报 ↗ |
| 2026-08-17 | Welgus Howard G. | 卖出 (S) | Common Stock | 4,730 | USD 26.18 | USD 123,831 | SEC 申报 ↗ |
| 2026-08-17 | Welgus Howard G. | 期权行权／转换 (M) | Common Stock | 4,096 | USD 7.93 | USD 32,473 | SEC 申报 ↗ |
| 2026-08-12 | Burnett Patrick | 卖出 (S) | Common Stock | 6,700 | USD 26.08 | USD 174,736 | SEC 申报 ↗ |
| 2026-08-12 | Burnett Patrick | 期权行权／转换 (M) | Common Stock | 6,700 | USD 3.64 | USD 24,388 | SEC 申报 ↗ |
| 2026-08-11 | Burnett Patrick | 卖出 (S) | Common Stock | 8,300 | USD 26.52 | USD 220,116 | SEC 申报 ↗ |
| 2026-08-11 | Burnett Patrick | 期权行权／转换 (M) | Common Stock | 8,300 | USD 3.64 | USD 30,212 | SEC 申报 ↗ |
| 2026-08-03 | Watanabe Todd | 卖出 (S) | Common Stock | 4,375 | USD 26.12 | USD 114,275 | SEC 申报 ↗ |
| 2026-08-03 | Matsuda Masaru | 卖出 (S) | Common Stock | 1,230 | USD 26.12 | USD 32,128 | SEC 申报 ↗ |
| 2026-08-03 | Burnett Patrick | 卖出 (S) | Common Stock | 955 | USD 26.12 | USD 24,945 | SEC 申报 ↗ |
| 2026-07-15 | Welgus Howard G. | 卖出 (S) | Common Stock | 4,730 | USD 26.91 | USD 127,284 | SEC 申报 ↗ |
| 2026-07-15 | Welgus Howard G. | 期权行权／转换 (M) | Common Stock | 4,096 | USD 7.93 | USD 32,473 | SEC 申报 ↗ |
| 2026-07-15 | Peetz Christopher | 奖励／授予 (A) | Common Stock | 4,315 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-17 | Welgus Howard G. | 卖出 (S) | Common Stock | 635 | USD 25.67 | USD 16,300 | SEC 申报 ↗ |
| 2026-06-15 | Welgus Howard G. | 卖出 (S) | Common Stock | 4,096 | USD 24.41 | USD 99,983 | SEC 申报 ↗ |
| 2026-06-15 | Welgus Howard G. | 期权行权／转换 (M) | Common Stock | 4,096 | USD 7.93 | USD 32,473 | SEC 申报 ↗ |
| 2026-06-15 | LIN SUE-JEAN | 卖出 (S) | Common Stock | 4,946 | USD 24.38 | USD 120,583 | SEC 申报 ↗ |
| 2026-06-05 | Welgus Howard G. | 奖励／授予 (A) | Common Stock | 5,778 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-05 | Munshi Amit | 奖励／授予 (A) | Common Stock | 5,778 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-05 | Leonard Keith R | 奖励／授予 (A) | Common Stock | 5,778 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-05 | LIN SUE-JEAN | 奖励／授予 (A) | Common Stock | 5,778 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-05 | Krishnamohan Neha | 奖励／授予 (A) | Common Stock | 5,778 | USD 0.00 | USD 0 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-18 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | ARQT |
| CIK | 0001787306 |
| 行业 | Healthcare |
| 细分行业 | Biotechnology Yahoo Finance |
| SEC SIC | 2834 Pharmaceutical Preparations |
| 交易所 | Nasdaq |
数据覆盖
| 本地 Form 4 历史 | 675 transaction lines from 2020-02-03 to 2026-09-16 29 P purchase lines · 348 S sale lines · 298 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.